A seven year old Hispanic girl developed headache,
backache and vomiting. A computed tomography showed 2
intracranial masses. A complete blood count was normal.
Bone marrow aspiration showed hypoplastic but otherwise
normal marrow. However, cerebrospinal fluid contained
leukemic myeloblasts. Four and a half years earlier the
patient had presented with an orbital mass, lethargy, and
loss of appetite. MRI demonstrated a mass in left maxillary
sinus extending to the left orbital cavity causing left
proptosis. Bone marrow aspiration was diagnostic of Acute
Myelogenous Leukemia (AML). She was treated with the
standard AML chemotherapy regimen. Patient achieved
complete remission and remained in remission during the
subsequent 4 and a half years until the above event.
AML recurrence after 4 years of remission is rare. In
addition this patient initially showed the recurrence only in
the extramedullary site which is also unusual. We
postulate that the intracranial recurrence was due to late
activation of latent leukemic cells that had seeded in the
leptomeningeal space at the time of original presentation.
Because of these 2 unusual aspects we wish to report this
case.
Open Access
Peer Reviewed
ISSN: 2378-8895
Pediatrics and Neonatal Care
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
Isolated Intracranial Relapse of Acute Myelocytic Leukemia (AML) Following 4 and 1/2 Years of Complete Remission
Faisal Niazi1, Susumu Inoue2*, Gagandeep Singh3, Nkechi Onwuzurike2, Elna Saah2 and Junaid Farooq1
Corresponding Author: Susumu Inoue
Received: Dec 31, 2014
Accepted: Mar 09, 2015
Published: Mar 12, 2015
Views: 4
DOI: 10.14437
Abstract
Susumu Inoue (2015), Isolated Intracranial Relapse of Acute Myelocytic Leukemia (AML) Following 4 and 1/2 Years of
Complete Remission. Pediatr Neonatal Care Open Access 3:114
Copyright:
Copyright: © 2015 PNCOA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Indexed In
Google Scholar
DOAJ
PubMed
Scopus